Engility Trial management for Biopharmaceutical
For emerging biotech and medical device companies, data integrity is a primary driver of asset value. To protect that value, teams need a user-friendly CTMS that streamlines study, monitoring and quality management, while funnelling critical documents into a unified eTMF. Inadequate data oversight can significantly devalue a clinical program in the eyes of partners and regulators. Engility™ offers a scalable, high-performance software platform designed for the budget of growing firms, supporting clinical & regulatory operating processes ensuring your data is audit-ready and your program's value is preserved.
John Young - Retired Chief Business Officer, Pfizer Inc. and Board Member Novartis
Benefits for Biopharma Companies
Allow study teams greater transparency and unified access to study information, allowing them to make informed decisions and reduce risk. Work together as a team or collaborate across sponsors and sites.
- Maintain trials oversight for internal and outsourced clinical trials
- Affordable enterprise technology reduces total cost of ownership
- Simplified access control promotes system sharing and partner collaboration
- Retain data assets and trial conduct experience with flexible sourcing models